Skip to main content

Table 2 ucRNA expression changes in LNCaP cells in response to treatment with epigenetic drugs

From: Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer

  Fold Change*,†    
ucRNA 5-AzaC TSA 5-AzaC + TSA Type‡, host gene, host strand Overlap with mRNA Antisense to mRNA
uc.308 + A 3.02 4.66 4.03 n, BTRC, sense Yes Yes
uc.434 + A 2.25 3.84 3.59 n, SKOR2, sense Yes  
uc.241 + A 2.03 2.31 3.12 n, no gene No  
uc.283 + A 1.90 2.17 2.39 n, no gene No  
uc.285+ 1.82 2.14 2.37 e, CCAR1, sense Yes  
uc.85+ 1.63 2.03 1.96 n, no gene No  
  1. * Fold change: reference are the untreated cells (solvent only); †Cutoff for inclusion: P value (t-test) < 0.01 treatment versus control; ‡ Type is based on UCSC human genome data, UCSC version hg19, NCBI build 37 coordinates, where, n = nonexonic and e = exonic.